Premium Information is available for this item - Upgrade for $1 a day
6550-01-588-1346
Reference Standard
6550015881346 015881346 D-004
INC: 77777
![]()
January 2023
1

Marketplace 6550-01-588-1346
Request a Quotation from participating marketplace vendors
Related Documents 6550-01-588-1346 1+ Documents (More...)
NE Related Documents 6550-01 Every Day 6550-01-588-1346 RQST Every Day 6550-01-588-1346 RQST Every Day
6550-01-588-1346 RQST 6550 -01 Every Day 6550-01 -588-1346 Restrictions 6550-01-588-1346 DEMIL: A |
Restrictions 6550-01-588-1346
6550-01-588-1346 is a Reference Standard that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
End Users 6550-01-588-1346
- Turkey (ZW01)
- Effective Date:
- 1 Sep 2010
Approved Sources 6550-01-588-1346
- Part Number
- Manufacturer
- Status
- D-004
- Manufacturer
- 3DH09 - Cerilliant Corporation (Active)
- Primary Buy
- Primary Buy
Datasheet 6550-01-588-1346
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- Special Features [FEAT]
- Acetonitrile Solvent; -82 Deg C Boiling Point; -45 Deg C Melting Point; 1.42 Vapor Density; 5.79 Evaporation Rate; Miscible Solubility; Colorless; Liquid; Ethereal Odor
Similar Supply Items to 6550-01-588-1346


















Freight Information 6550-01-588-1346
6550-01-588-1346 has freight characteristics managed by Turkey.. 6550-01-588-1346 has a variance between NMFC and UFC when transported by rail and the description should be consulted.